Patrick Trojer

Dr. Patrick Trojer is a seasoned biopharmaceutical executive with extensive experience in drug discovery and development. He is the founder and current President & CEO of Triana Biomedicines, a venture-backed company focused on pioneering novel therapeutics through molecular glue discovery using AI and structural biology. Dr. Trojer joined Triana in November 2021, bringing a wealth of expertise from his previous role as Chief Scientific Officer at Constellation Pharmaceuticals. He holds a PhD from Leopold-Franzens Universität Innsbruck and has a strong background in molecular biology and biochemistry, contributing significantly to advancements in targeted therapies.